ISORDIL Drug Patent Profile
✉ Email this page to a colleague
When do Isordil patents expire, and when can generic versions of Isordil launch?
Isordil is a drug marketed by Wyeth Ayerst, Bausch, and Biovail. and is included in three NDAs.
The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isordil
A generic version of ISORDIL was approved as isosorbide dinitrate by ENDO OPERATIONS on March 12th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISORDIL?
- What are the global sales for ISORDIL?
- What is Average Wholesale Price for ISORDIL?
Summary for ISORDIL
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 6 |
Patent Applications: | 3,870 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ISORDIL |
What excipients (inactive ingredients) are in ISORDIL? | ISORDIL excipients list |
DailyMed Link: | ISORDIL at DailyMed |
![ISORDIL drug patent expirations Drug patent expirations by year for ISORDIL](/p/graph/s/t/ISORDIL-patent-expirations.png)
![Drug Prices for ISORDIL](/p/graph/drug-price/ISORDIL.png)
Recent Clinical Trials for ISORDIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Hospital Medical Center, Cincinnati | Phase 2 |
Brigham and Women's Hospital | Phase 4 |
University of Cape Town | Phase 3 |
Pharmacology for ISORDIL
Drug Class | Nitrate Vasodilator |
Physiological Effect | Vasodilation |
US Patents and Regulatory Information for ISORDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | ISORDIL | isosorbide dinitrate | CAPSULE, EXTENDED RELEASE;ORAL | 012882-002 | Jul 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-001 | Jul 29, 1988 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-002 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |